3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
249
Active not recruiting
185
Completed
66
Terminated
28
Not yet recruiting
23
Withdrawn
5
Enrolling by invitation
2
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Specimen Handling
29
Magnetic Resonance Spectroscopy
20
Biopsy
19
Cyclophosphamide
8
venetoclax
5
Bevacizumab
5
Vincristine
4
Taxes
4
Surgical Procedures, Operative
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Etoposide
4
Cetuximab
4
Azacitidine
4
fludarabine phosphate
3
fludarabine
3
decitabine and cedazuridine drug combination
3
X-Rays
3
Radiosurgery
3
Radiation
3
Prednisone
3
Doxorubicin
3
zanubrutinib
2
trastuzumab deruxtecan
2
prednylidene
2
olaparib
2
iadademstat
2
deltacortene
2
Tacrolimus
2
Standard of Care
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
pembrolizumab
×
90 days
×
Clear all
NCT04266730
2026-04-23
PANDA-VAC
UNC Lineberger Comprehensive Cancer Center
Phase 1
Suspended
6 enrolled